A Predictive Bayesian Approach to the Design and Analysis of Bridging Studies

Confirmatory phase 3 trials provide the evidence for the efficacy and safety of a product needed for regulatory approval to market the product. Although these trials may be large and reflect the experience of thousands of patients, they necessarily are limited in scope and may not include the experience of patients in all countries.